A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
Phase 1
Recruiting
- Conditions
- Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Registration Number
- CTIS2023-504583-42-00
- Lead Sponsor
- Eli Lilly & Co.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Be overweight., Have no Type 2 diabetes or has Type 2 diabetes and treated with diet and exercise only with stable doses of up to 3 oral diabetic medications., Have been diagnosed with CKD.
Exclusion Criteria
Have a change in body weight greater than 11 pounds., Have Type 1 Diabetes, Have acute or chronic hepatitis, Have a history of cancer within 5 years before screening.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method